Cargando…
Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin
Euglycemic diabetic ketoacidosis (EDKA) is an uncommon diabetic complication with increasing prevalence and is associated with the use of sodium-glucose co-transporter 2 inhibitors (SGLT2i). We report the case of a 77-year-old female patient with type 2 diabetes mellitus, treated with metformin/lina...
Autores principales: | Fustiga, João, Fernandes, Marco, Dâmaso, Francisca, Duarte, Joana A, Rodrigues, Catarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885381/ https://www.ncbi.nlm.nih.gov/pubmed/36726923 http://dx.doi.org/10.7759/cureus.33161 |
Ejemplares similares
-
Empagliflozin: Euglycemic and hyperglycaemic diabetic ketoacidosis: case report
Publicado: (2021) -
Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis
por: Calçada, Marta Brandão, et al.
Publicado: (2021) -
SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019) -
Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports
por: Altowayan, Waleed M.
Publicado: (2022) -
Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient
por: Rathore, Azeem, et al.
Publicado: (2023)